Insider Buying: Adtalem Global Education (NYSE:CVSA) Director Acquires 15,305 Shares of Stock

Key Points

• Insider purchase: Director Michael Malafronte acquired 15,305 shares on March 10 at an average price of $100.86, a $1.54 million transaction that raised his holdings to 16,505 shares (a 1,275.42% increase).
• Company fundamentals: CVSA traded near $100.90 (down 0.2%); Adtalem has a $3.48 billion market cap, P/E of 14.82, and last reported quarterly EPS of $2.43 on $503.39 million revenue with a 20.24% ROE and 13.41% net margin.
• Analyst view: The consensus rating is "Buy" with a $170 target, supported by recent notes including Zacks' upgrade to "strong-buy" and Barrington's "outperform."

Adtalem Global Education Inc. (NYSE:CVSA - Get Free Report) Director Michael Malafronte acquired 15,305 shares of the business's stock in a transaction that occurred on Tuesday, March 10th. The shares were acquired at an average cost of $100.86 per share, for a total transaction of $1,543,662.30. Following the completion of the acquisition, the director owned 16,505 shares of the company's stock, valued at $1,664,694.30. This trade represents a 1,275.42% increase in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Adtalem Global Education Stock Down 0.2%

Adtalem Global Education stock traded down $0.20 during mid-day trading on Thursday, reaching $100.90. 43,310 shares of the company were exchanged, compared to its average volume of 434,531. The company has a quick ratio of 0.68, a current ratio of 0.68 and a debt-to-equity ratio of 0.37. The firm has a market cap of $3.48 billion, a P/E ratio of 14.82, a P/E/G ratio of 0.85 and a beta of 0.72. Adtalem Global Education Inc. has a 12-month low of $86.97 and a 12-month high of $156.26.

Adtalem Global Education (NYSE:CVSA - Get Free Report) last announced its quarterly earnings results on Wednesday, January 28th. The company reported $2.43 earnings per share (EPS) for the quarter. The business had revenue of $503.39 million for the quarter. Adtalem Global Education had a return on equity of 20.24% and a net margin of 13.41%.

Analyst Upgrades and Downgrades

A number of research firms have recently weighed in on CVSA. Zacks Research upgraded shares of Adtalem Global Education from a "hold" rating to a "strong-buy" rating in a report on Tuesday, February 24th. Weiss Ratings initiated coverage on shares of Adtalem Global Education in a research note on Wednesday, February 25th. They issued a "hold (c+)" rating for the company. Finally, Barrington Research reaffirmed an "outperform" rating and set a $170.00 price target on shares of Adtalem Global Education in a research report on Monday, March 2nd. One research analyst has rated the stock with a Strong Buy rating, one has assigned a Buy rating and one has issued a Hold rating to the company's stock. According to MarketBeat.com, Adtalem Global Education currently has an average rating of "Buy" and a consensus target price of $170.00.

Adtalem Global Education Company Profile

Adtalem Global Education NYSE: CVSA is a provider of higher education and workforce solutions focused primarily on programs that prepare students for professional careers in healthcare, medicine, veterinary medicine and related fields. The company operates campus-based and online degree programs, continuing professional education, clinical training and exam-preparation offerings designed to support students seeking licensure and employment in regulated professions.

Adtalem’s portfolio includes institution brands that deliver undergraduate, graduate and professional training across nursing, medicine, veterinary medicine and allied health disciplines.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.